BriaCell Therapeutics Corp.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Rok finansowy 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% -inf%
EBIT (mln) -0 -0 -0 -0 -0 -1 -1 -0 -0 -1 -2 -3 -4 1 1 4 -15 -23 -33
EBIT Δ r/r 0.0% 1404.0% -11.6% 104.9% 38.8% 224.5% 13.8% -64.6% 3.1% 229.4% 15.7% 54.9% 47.9% -124.8% 46.3% 166.5% -514.4% 52.2% 41.0%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA (mln) -0 -0 -0 -0 0 -1 -0 -0 7 -0 -2 -3 1 1 1 4 -12 -22 -5
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 0 -0 -0 0 1 -0 -0 -0 8 2 1 1 2 0 -0 7 0 0 0
Zysk Netto (mln) -0 -0 -0 -0 -1 -1 -1 -0 -8 -3 -2 -3 1 1 1 -3 -12 -20 -5
Zysk netto Δ r/r 0.0% 1256.6% -15.0% 131.3% 293.7% 19.8% -7.7% -63.0% 2109.5% -67.1% -36.8% 52.4% -141.2% -43.4% 129.7% -309.1% 300.1% 75.3% -76.4%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS -4.18 -27.92 -20.45 -25.62 -49.58 -33.02 -16.93 -6.25 -138.07 -10.76 -5.88 -7.61 2.49 1.04 1.94 -0.64 -0.75 -1.3 -0.29
EPS (rozwodnione) -4.18 -27.92 -20.45 -25.62 -49.58 -33.02 -16.93 -6.25 -138.07 -10.76 -5.88 -7.32 2.49 1.04 1.94 -0.64 -0.75 -1.3 -0.29
Ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 5 15 16 16
Ważona ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 5 15 16 16
Waluta CAD CAD CAD CAD CAD CAD CAD CAD CAD CAD CAD CAD CAD CAD CAD USD USD USD USD